Granules India Ltd.

View in App
276.95 +3.90 ▲1.4%

26 May 2023, 04:01:00 PM
Volume: 55,004

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.granulesindia.com
Market Cap 6,703.37 Cr.
Enterprise Value(EV) 7,449.21 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 21.34 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 12.98 Trailing Twelve Months Ending 2023-03
Industry PE 31.87 Trailing Twelve Months Ending 2023-03
Book Value / Share 117.12 Trailing Twelve Months Ending 2023-03
Price to Book Value 2.36 Calculated using Price: 276.95
Dividend Yield 0.54 Period Ending 2022-03
No. of Shares Subscribed 24.20 Cr. 242,042,756 Shares
FaceValue 1
About Granules India Ltd.
Granules India is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs).

Granules India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Granules India Ltd. Performance

View details >>
1 Day
+1.43%
1 Week
+0.47%
1 Month
-7.51%
3 Month
-2.93%
6 Month
-22.30%
1 Year
+7.10%
2 Year
-13.13%
5 Year
+248.58%
10 Year
+2043.58%

Granules India Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.20 23.29 23.53 18.23 10.60 13.32 18.54 27.64 17.49
Return on Capital Employed (%) 19.90 18.81 20.16 16.57 11.09 12.71 17.22 25.42 17.37
Return on Assets (%) 8.98 8.28 9.03 8.12 5.13 6.64 9.99 15.84 10.04

Granules India Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 356 431 662 904 1,304 1,529 1,844 2,173 2,587 2,835
Non Curr. Liab. 344 357 247 188 488 553 486 366 283 255
Curr. Liab. 293 415 655 787 878 896 893 1,173 1,642 1,814
Minority Int. 1
Equity & Liab. 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903
Non Curr. Assets 612 700 745 1,051 1,484 1,696 1,594 1,716 2,007 2,329
Curr. Assets 377 500 818 828 1,187 1,282 1,629 1,997 2,505 2,574
Misc. Exp. not W/O 4 3
Total Assets 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903

Granules India Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 1,096 1,294 1,357 1,411 1,685 2,279 2,599 3,238 3,765 4,512
Other Income 4 4 6 10 11 27 37 27 18 14
Total Income 1,100 1,297 1,363 1,420 1,695 2,306 2,635 3,264 3,783 4,526
Total Expenditure -938 -1,084 -1,081 -1,112 -1,406 -1,895 -2,073 -2,382 -3,043 -3,598
PBIDT 163 213 282 309 289 411 562 882 740 928
Interest -20 -32 -37 -32 -33 -28 -27 -26 -23 -56
Depreciation -30 -53 -58 -72 -76 -105 -137 -151 -159 -185
Taxation -37 -37 -61 -65 -63 -89 -116 -155 -145 -171
Exceptional Items 28
PAT 75 91 125 140 117 188 310 549 413 517
Minority Interest
Share Associate -2 25 16 49 25
Other Related Items
Consolidated Net Profit 75 91 123 165 133 236 335 549 413 517
Adjusted EPS 4 4 6 7 5 9 13 22 17 21

Granules India Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 91 108 150 151 188 -1 262 476 432 332
Cash Fr. Inv. -128 -255 -146 -162 -326 -462 -270 -161 -277 -380
Cash Fr. Finan. 46 147 19 86 56 529 -17 -213 -299 190
Net Change 10 0 24 75 -82 66 -25 103 -144 142
Cash & Cash Eqvt 42 42 65 130 42 108 83 186 42 185

Granules India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 42.04 42.04 42.04 41.98 41.98 41.98 41.93 42.02 42.02
Public 57.96 57.96 57.96 58.02 58.02 58.02 58.07 57.98 57.98
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 8.64 6.92 6.92 6.92 6.92 10.59 10.59 4.03 4.03

Granules India Ltd. Announcements

View details >>
Thu, 25 May 2023
Intimation
Intimation
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report under Regulation 24A for the FY 2022-23
Tue, 23 May 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/ Investor Meet

Granules India Ltd. Technical Scans

View details >>
Fri, 26 May 2023
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 6 Months High Decrease in 6 Months
High Increase in 5 Years High Increase in 5 Years
20 SMA Crossing 50 SMA From Above 20 SMA Crossing 50 SMA From Above

Granules India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Granules India Ltd. FAQ's

What is Granules India share price?
Can I buy Granules India shares now?
What is the Dividend Yield of Granules India?
What is the Market Cap of Granules India?
What are the key metrics to analyse Granules India?
What is the 52 Week High and Low of Granules India?
What is the trend of Granules India share price?